Research & Development



  董仲舒的面色緩和了一些,嘆口氣道︰“甚好。”   喝了一壺酒之後,劉徹就覺得自己實在是太大度了,連處罰雲瑯的心思都淡了。用生日号怎么买彩票   他們唯一認同的,就是借用這次儒家的辯論會,聯絡那些有錢有勢的地方賢達,共同構築出一個以劉徹為核心的巨型商業體系。彩票生日选号器   “早有耳聞,老夫當年去齊地遍尋不到,深以為憾,卻不料璇璣城卻進京了。” 第一三四章 往事不可追中国福利彩票双色球基本走势图   “那麼,那個總是賴在我們家書房里的金日比之小光,跟安世又如何呢?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo